What are the diagnostic tests for celiac disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Tests for Celiac Disease

Initial Screening Test

The IgA tissue transglutaminase antibody (tTG-IgA) is the single best initial screening test for celiac disease, with sensitivity of 90-96% and specificity >95%. 1, 2, 3

  • Total serum IgA level must be measured simultaneously to rule out IgA deficiency, which occurs in 1-3% of celiac patients and causes false-negative tTG-IgA results 2, 3, 4
  • Testing must be performed while the patient consumes at least 10g of gluten daily for 6-8 weeks before testing, as starting a gluten-free diet leads to false-negative results 2, 3, 4
  • The older IgA/IgG antigliadin antibody tests are not recommended due to poor diagnostic performance compared to tTG-IgA 1, 5

Confirmatory Serologic Testing

When tTG-IgA is elevated (especially >10× upper limit of normal), IgA endomysial antibody (EMA-IgA) should be performed as confirmatory testing with excellent specificity of 99.6% 1, 2, 3

  • The combination of tTG-IgA >10× upper limit of normal plus positive EMA-IgA approaches 100% positive predictive value for celiac disease 2, 4
  • EMA-IgA has sensitivity of 88-94.5% and specificity of 93.8-99.6%, making it useful for ruling in disease 1
  • There is no advantage to using a panel of multiple serologic tests over the two-step tTG-IgA followed by EMA-IgA approach 1, 5

Gold Standard: Intestinal Biopsy

Upper endoscopy with multiple duodenal biopsies remains the gold standard for diagnosis in adults, even when antibody levels are highly elevated 1, 2, 4

  • At least 6 biopsy specimens total should be obtained: 1-2 from the duodenal bulb and at least 4 from the second part of the duodenum or beyond 1, 2, 4
  • Multiple biopsies are necessary because mucosal changes can be patchy 1
  • Characteristic histologic findings include villous atrophy, crypt lengthening, and increased intraepithelial lymphocytes 1, 2, 3
  • Isolated intraepithelial lymphocytosis without villous atrophy is not diagnostic of celiac disease and requires consideration of other causes 3

Testing in IgA-Deficient Patients

In patients with IgA deficiency, IgG-based tests must be used instead: IgG deamidated gliadin peptide (DGP-IgG) or IgG tissue transglutaminase (tTG-IgG) 1, 2, 3

  • IgG-based tests have excellent sensitivity and specificity in IgA-deficient patients 1
  • IgG-based tests are markedly less accurate in patients with normal IgA levels and should not be used in that setting 2

HLA Genetic Testing

HLA-DQ2 and HLA-DQ8 testing has >99% negative predictive value—absence of both alleles essentially rules out celiac disease 2, 3, 4

HLA testing is useful in specific scenarios:

  • When celiac disease is strongly suspected despite negative serology 1, 2, 4
  • In patients with equivocal biopsy findings 2, 3
  • In patients already on a gluten-free diet who were never properly tested 2, 3
  • HLA testing is NOT useful for diagnosis confirmation when tTG-IgA is highly elevated, as it adds no diagnostic value in this scenario 4

Special Population Considerations

In children under 2 years of age, tTG-IgA should be combined with IgG and IgA deamidated gliadin peptides for improved sensitivity 2, 3, 4

Biopsy may be avoided in children (but not adults) with all three criteria: tTG-IgA ≥10× upper limit of normal, positive EMA-IgA, and positive HLA-DQ2/DQ8 2, 3

Critical Pitfalls to Avoid

Starting a gluten-free diet before completing diagnostic testing is the most common error and leads to false-negative serologic and histologic results 2, 3

  • Patients who have already started a gluten-free diet must resume normal diet with three slices of wheat bread daily for 1-3 months before repeat testing 2, 3
  • Some patients may require several years of gluten challenge for histologic relapse to occur 2

Relying solely on serology without biopsy confirmation in adults leads to misdiagnosis 2, 3

Negative serology after treatment does not guarantee intestinal mucosal healing—approximately 50% of patients with persistent villous atrophy on gluten-free diet have normal tTG-IgA levels 6, 7

  • Follow-up serology should be performed at 6 and 12 months after diagnosis, then yearly 2, 3
  • Patients with persistent or relapsing symptoms require repeat endoscopic biopsies to determine healing, even with negative tTG-IgA 2

Diagnostic Algorithm for Negative Serology with High Clinical Suspicion

When serology is negative but clinical suspicion remains high:

  1. Confirm patient is consuming adequate gluten (at least 10g daily for 6-8 weeks) 2
  2. Verify total IgA level is normal 2
  3. Perform HLA-DQ2/DQ8 testing—if positive, proceed to biopsy 2
  4. If HLA is negative, celiac disease is essentially ruled out 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Celiac Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Celiac Disease Diagnostic Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Celiac Disease Diagnosis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.